Autotransfusion Blood Bags

Autotransfusion Blood Bags Market Outlook

The global autotransfusion blood bags market is projected to reach approximately USD 1.2 billion by 2035, growing at a compound annual growth rate (CAGR) of 6.8% from 2025 to 2035. The increasing prevalence of surgical procedures, along with a rise in trauma cases requiring blood transfusions, acts as a significant growth factor for this market. Furthermore, advancements in medical technology and improved healthcare infrastructure are enabling better blood management practices, thereby boosting the demand for autotransfusion blood bags. Increased awareness among patients regarding the benefits of autologous blood transfusions also contributes positively to the market dynamics. As healthcare systems evolve, the emphasis on patient safety and minimizing the risk of transfusion-related complications is driving the adoption of autotransfusion systems, ensuring a strong market trajectory in the coming years.

Growth Factor of the Market

One of the primary growth factors of the autotransfusion blood bags market is the rising geriatric population worldwide, which is more susceptible to chronic illnesses and often requires surgical interventions. Additionally, the increasing incidence of cardiovascular diseases and orthopedic disorders fuels the demand for surgical procedures that utilize autotransfusion blood bags. Enhanced healthcare policies focused on patient safety and the growing trend of minimally invasive surgeries are further propelling market growth. Moreover, the development of innovative blood management systems and automated blood collection technologies has significantly improved the efficiency and safety of the transfusion process. Coupled with the increasing number of blood donation initiatives and campaigns across various regions, these factors create a supportive environment for the market's expansion.

Key Highlights of the Market

• The market is expected to witness a CAGR of 6.8% from 2025 to 2035.
• North America is projected to dominate the market share due to advanced healthcare systems and higher surgical procedure rates.
• Single blood bags are anticipated to hold the largest share in the product type segment.
• Orthopedic surgeries are expected to be the leading application area for autotransfusion blood bags.
• The growing emphasis on patient safety is driving the shift towards autologous blood transfusion practices.

By Product Type

Single Blood Bags:

Single blood bags are the most commonly used type of autotransfusion blood bags, primarily designed to collect, store, and transfuse blood from a single donor. Their significant market share is attributed to their versatility and ease of use in a variety of surgical settings. These bags typically come equipped with a connector and a needle to facilitate the efficient collection of blood directly from the patient during surgery. Furthermore, the single blood bag system minimizes the risk of contamination and ensures a streamlined transfusion process. As hospitals and surgical centers implement more rigorous blood management protocols, the demand for single blood bags is expected to rise significantly, solidifying their position in the autotransfusion market.

Double Blood Bags:

Double blood bags are designed to collect and separate two components of blood, allowing for efficient transfusion of both red blood cells and plasma. This functionality makes them particularly valuable in surgical environments where rapid access to different blood components is critical for patient care. The use of double blood bags helps optimize blood resource management by enabling healthcare providers to transfuse specific blood components as needed. As a result, they are increasingly being adopted in hospitals and surgical centers, especially during complex surgeries where multiple transfusions may be required. The growth in the demand for double blood bags is expected to continue as healthcare systems strive to enhance patient care through tailored blood transfusion practices.

Triple Blood Bags:

Triple blood bags offer a unique advantage by allowing the collection and separation of three blood components, namely red blood cells, plasma, and platelets, in a single process. This capability is especially beneficial in trauma cases and major surgeries where multiple blood products may be required promptly. The increasing number of surgeries involving significant blood loss is driving the demand for triple blood bags as they provide a more efficient solution for blood component management. Moreover, advancements in technology have improved the design and functionality of triple blood bags, ensuring enhanced safety and reduced risk of contamination. As healthcare providers prioritize the availability of critical blood components, the market for triple blood bags is anticipated to see significant growth.

Quadruple Blood Bags:

Quadruple blood bags facilitate the collection and separation of four distinct blood components, thus maximizing the utility of each donation. These bags are particularly beneficial in healthcare settings that handle a high volume of complex surgical procedures requiring various blood products. The ability to efficiently produce multiple components from a single blood donation enhances blood resource utilization and minimizes waste. As the focus on personalized medicine and precise transfusion practices increases, the demand for quadruple blood bags is expected to rise, especially in advanced healthcare systems. They provide a significant advantage in managing the needs of patients, especially in critical situations, where timely access to different blood components is vital.

Quintuple Blood Bags:

Quintuple blood bags are designed to separate and store five individual blood components, allowing for optimal resource management in transfusion medicine. This type of blood bag is particularly useful in large hospitals and blood banks that face high demand for specific blood components. By efficiently utilizing each donation to yield various components—including red blood cells, plasma, and platelets—quintuple blood bags help address the needs of multiple patients simultaneously. As the healthcare sector continues to evolve and adopt more sophisticated blood management practices, the quintuple blood bags are expected to gain traction, providing a comprehensive solution to maximize the potential of blood donations.

By Application

Orthopedic Surgeries:

Orthopedic surgeries frequently involve significant blood loss, necessitating effective blood transfusion strategies. Autotransfusion blood bags play a critical role in these procedures, enabling the collection of the patient's own blood during surgery to be reinfused later. This not only minimizes the need for allogeneic blood transfusions, which carry a risk of adverse reactions but also enhances patient safety and recovery. With the increasing prevalence of orthopedic surgeries, especially in an aging population, the demand for autotransfusion blood bags in this application is anticipated to rise significantly. Hospitals are increasingly adopting these practices as they recognize the benefits of using autologous blood to improve surgical outcomes and reduce complications.

Cardiovascular Surgeries:

Cardiovascular surgeries often require meticulous blood management due to the high risk of blood loss and the critical nature of these procedures. Autotransfusion blood bags allow for the safe collection and reinfusion of blood, particularly in cases where patients are at increased risk for complications from traditional transfusions. Utilizing autotransfusion techniques not only reduces the risk of transfusion-related infections but also addresses the growing concern about blood supply shortages. As the incidence of cardiovascular diseases rises globally, thereby increasing the volume of surgeries performed, the demand for autotransfusion blood bags in this application is projected to grow, enhancing patient care and safety during and after surgery.

Organ Transplantation:

Organ transplantation procedures often involve substantial blood loss, making effective blood management essential for successful outcomes. Autotransfusion blood bags allow for the collection of the patient's blood during surgery, which can then be reinfused, thereby minimizing the need for donor blood and its associated risks. The increasing number of organ transplant surgeries globally is driving the demand for autotransfusion blood bags, as healthcare providers strive to improve patient outcomes and reduce postoperative complications. Moreover, advancements in surgical techniques and blood management systems are ensuring the consistent and safe use of autotransfusion methods in transplant surgeries, further bolstering the need for these blood bags.

Trauma Cases:

In trauma cases, rapid and effective blood transfusion is crucial for patient stabilization and survival. Autotransfusion blood bags play an essential role in these emergency situations, allowing for immediate collection and reinfusion of the patient's own blood. This practice not only reduces reliance on external blood supplies but also minimizes the risk of transfusion-related complications. With the increasing occurrence of accidents and violence globally, the demand for autotransfusion blood bags in trauma management is expected to rise significantly. Emergency medical services and trauma centers are increasingly leveraging autotransfusion techniques to enhance patient outcomes and streamline emergency care processes, thus driving market growth.

Others:

Aside from the primary applications of orthopedic surgeries, cardiovascular surgeries, organ transplantation, and trauma cases, autotransfusion blood bags are also utilized in various other medical procedures. This includes elective surgeries, dental procedures, and even some cancer treatments where blood loss may occur. The versatility of autotransfusion blood bags expands their applicability across various medical disciplines, thus contributing to their market growth. Moreover, the evolving landscape of healthcare practices, including the increasing emphasis on personalized medicine and patient safety, is encouraging the adoption of autotransfusion techniques in less conventional applications. As awareness of the benefits of autotransfusion continues to spread, it is likely that the demand for these blood bags will increase across multiple medical fields.

By Distribution Channel

Hospitals:

Hospitals are the primary distribution channel for autotransfusion blood bags, as they are the main providers of surgical and emergency care. The demand for these blood bags in hospitals is driven by the increasing number of surgeries performed and the growing emphasis on patient safety and blood management. Hospital settings are equipped with the necessary infrastructure and trained personnel to utilize autotransfusion techniques effectively. Additionally, hospitals often implement protocols that prioritize the use of autologous blood, further supporting the demand for autotransfusion blood bags. As surgical volumes continue to rise, the hospital distribution channel is expected to remain a dominant force in the market.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) are emerging as a significant distribution channel for autotransfusion blood bags, especially as the trend toward outpatient surgical procedures continues to grow. These centers often perform a high volume of orthopedic and minor surgical procedures, making the need for efficient blood management solutions paramount. The ability to quickly collect and reinfuse a patient’s own blood during an ASC procedure enhances patient outcomes while minimizing the risks associated with allogeneic blood transfusions. As more patients opt for outpatient surgery due to shorter recovery times and lower costs, the relevance of autotransfusion blood bags in ASCs will likely increase, thus contributing to market growth.

Blood Banks:

Blood banks serve as critical distribution channels for autotransfusion blood bags, facilitating the collection, testing, and storage of blood products. Autotransfusion blood bags are often utilized in blood banks to promote the safe collection of autologous blood donations, thereby expanding the available blood supply for patients in need. As the demand for blood continues to rise, blood banks are increasingly adopting autotransfusion techniques to enhance their operational efficiency and efficacy. The collaboration between blood banks and healthcare facilities is essential to ensure that autotransfusion products are readily available for surgical procedures, thereby driving the growth of this segment in the market.

Others:

In addition to the primary distribution channels of hospitals, ambulatory surgical centers, and blood banks, other distribution channels include clinics, home healthcare services, and online medical supply retailers. These alternative channels are gaining traction as healthcare delivery models evolve and shift towards more decentralized approaches. The growing trend of home healthcare requires access to medical supplies like autotransfusion blood bags, enhancing their demand in non-traditional settings. Additionally, the rise of telemedicine and online healthcare services is leading to increased accessibility of medical supplies, thus supporting the growth of autotransfusion blood bags in various distribution channels beyond conventional healthcare settings.

By Material Type

PVC:

PVC (polyvinyl chloride) is the most commonly used material for manufacturing autotransfusion blood bags due to its favorable properties, such as flexibility, chemical stability, and cost-effectiveness. PVC bags provide excellent barrier properties, which are critical for the storage and preservation of blood components. Moreover, they can be easily molded into various shapes and sizes, making them suitable for different blood bag configurations. The widespread adoption of PVC in the medical field, coupled with its compatibility with sterilization processes, ensures that it remains the preferred choice for many manufacturers. As hospitals and healthcare systems increasingly focus on cost efficiency, the demand for PVC-based autotransfusion blood bags is expected to continue growing in the foreseeable future.

Polyolefin:

Polyolefin materials are becoming increasingly popular in the production of autotransfusion blood bags due to their superior properties compared to traditional PVC. Polyolefin bags offer enhanced puncture resistance, lower leachability, and improved compatibility with various blood components, thereby ensuring better quality preservation during storage. Additionally, polyolefin is a more environmentally friendly alternative, appealing to healthcare institutions that prioritize sustainability and eco-friendliness in their operations. As medical technology advancements continue to evolve, the demand for polyolefin autotransfusion blood bags is likely to rise, driven by the need for high-performance materials that enhance patient safety and improve blood management practices.

TPU:

Thermoplastic polyurethane (TPU) is gaining traction as a material choice for autotransfusion blood bags due to its exceptional biocompatibility and flexibility. TPU bags exhibit excellent mechanical properties, providing durability and resistance to wear and tear, which is particularly important in high-demand medical environments. Furthermore, the ability to produce bags with thin walls while maintaining strength makes TPU an attractive option for manufacturers seeking to optimize the volume and weight of blood bags. As the industry seeks to improve patient outcomes through enhanced materials, the adoption of TPU in autotransfusion blood bags is expected to see significant growth in the coming years.

Others:

In addition to PVC, polyolefin, and TPU, other materials such as medical-grade polyethylene and copolymer materials are also used in the production of autotransfusion blood bags. These alternative materials are being explored due to their unique properties, such as enhanced barrier performance and reduced risk of contamination. Although these materials currently represent a smaller segment of the market, they are gradually gaining acceptance as manufacturers innovate to meet evolving healthcare standards and patient safety requirements. As research into advanced materials continues, the use of alternative materials in autotransfusion blood bags may expand, offering healthcare providers a wider range of options to suit their specific needs.

By Region

The global autotransfusion blood bags market is segmented by region, with North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa exhibiting distinct market characteristics. North America is projected to hold the largest market share due to advanced healthcare infrastructure, a high incidence of surgical procedures, and a growing emphasis on patient safety. The region is expected to witness a CAGR of approximately 7.2% over the forecast period, driven by technological advancements and an increasing number of healthcare initiatives promoting autologous blood transfusion practices. In Europe, factors such as the aging population and rising awareness of the benefits of autotransfusion are contributing to market growth, while Asia Pacific is expected to emerge as a significant growth area due to expanding healthcare access and rising surgical volumes.

In Latin America, the autotransfusion blood bags market is anticipated to grow steadily due to improving healthcare facilities and increased government support for blood donation programs. The Middle East & Africa region presents certain challenges, including varying healthcare standards and limited access to medical resources. However, there is a growing trend toward modernization of healthcare facilities and an increased focus on patient safety, which is expected to drive the demand for autotransfusion blood bags over time. As the regional healthcare landscape continues to evolve, the overall market is likely to benefit from increased investments and innovations in blood management practices.

Opportunities

The autotransfusion blood bags market presents numerous opportunities for growth and innovation, particularly as healthcare systems globally continue to evolve. One significant opportunity lies in the increasing demand for minimally invasive surgical techniques, which often necessitate effective blood management strategies. As more healthcare providers adopt these techniques, the need for autotransfusion blood bags to facilitate efficient blood collection and reinfusion is expected to rise. Additionally, the ongoing research and development efforts aimed at enhancing the design and functionality of blood bags provide fertile ground for manufacturers to introduce innovative products that meet the changing needs of healthcare providers. Expansion into emerging markets, where healthcare infrastructure is rapidly improving, also presents a lucrative opportunity for companies willing to invest in these regions.

Furthermore, strategic partnerships and collaborations between manufacturers and healthcare organizations can create opportunities for growth by enhancing product distribution and accessibility. Developing educational initiatives to promote the benefits of autologous blood transfusion among healthcare professionals and patients can also drive market adoption. As the focus on patient safety and personalized medicine strengthens, the potential for autotransfusion blood bags to play a pivotal role in ensuring optimal patient outcomes is immense. Overall, the market landscape is rich with opportunities that businesses can leverage to enhance their market presence and drive growth in the autotransfusion blood bags sector.

Threats

Despite the promising growth trajectory of the autotransfusion blood bags market, there are several threats that could potentially hinder its progress. One major concern is the stringent regulatory requirements governing medical devices, which can significantly delay the introduction of new products to the market. Compliance with these regulations often necessitates extensive testing and validation processes, placing a burden on manufacturers and increasing costs. Additionally, the emergence of alternative blood management solutions, such as automated blood collection systems and advanced blood processing technologies, poses a competitive threat to traditional autotransfusion methods. If these alternatives gain widespread acceptance among healthcare providers, it could impact the demand for autotransfusion blood bags.

Moreover, fluctuations in raw material prices and potential supply chain disruptions can affect production costs and lead to pricing pressures in the market. The unpredictability of global economic conditions, including factors such as inflation and trade policies, can create challenges for manufacturers seeking to maintain profitability. Furthermore, the ongoing impact of the COVID-19 pandemic has highlighted vulnerabilities in the healthcare supply chain, potentially leading to shortages of essential medical supplies, including autotransfusion blood bags. Consequently, businesses must remain agile and adaptable to navigate these threats and develop strategies to mitigate their impact on market growth.

Competitor Outlook

• Terumo Corporation
• Haemonetics Corporation
• Medtronic plc
• Baxter International Inc.
• Grifols S.A.
• Fresenius Kabi AG
• BloodBank Technology
• Macopharma
• JMS Co., Ltd.
• Reliance Medical Limited
• Cardinal Health, Inc.
• Vygon SA
• HemoCue AB
• HemaCare Corporation
• Graham-Field Health Products, Inc.

The competitive landscape of the autotransfusion blood bags market is characterized by a mix of established players and emerging companies striving to innovate and capture market share. Major companies such as Terumo Corporation, Haemonetics Corporation, and Medtronic plc dominate the market, leveraging their extensive experience, robust distribution networks, and strong brand recognition to maintain their positions. These companies are continuously investing in research and development to enhance product quality and introduce innovative solutions that cater to the evolving needs of healthcare providers. Additionally, collaborations and strategic partnerships between these companies and healthcare institutions are key to driving innovation and expanding market reach.

Other notable players like Baxter International Inc. and Grifols S.A. are also focusing on product diversification and expanding their product portfolios to include advanced blood management solutions. The focus on sustainability and environmentally friendly practices is becoming increasingly important in the competitive landscape, prompting companies to explore alternative materials and production methods for blood bags. As the market continues to evolve, the competitive environment is expected to intensify, with players striving to differentiate themselves through quality, innovation, and customer service. Companies are also increasingly looking towards emerging markets to fuel their growth, recognizing the potential for expansion in regions with improving healthcare infrastructure and rising surgical volumes.

In addition to the established companies, a number of smaller firms are entering the autotransfusion blood bags market, often bringing innovative technologies and niche products to the table. Companies such as BloodBank Technology and Macopharma are carving out their positions by focusing on specialized blood management solutions that meet the unique needs of certain healthcare settings. Furthermore, these emerging players are often more agile, allowing them to respond swiftly to market changes and emerging trends. As the industry landscape shifts, the interplay between established players and new entrants will be crucial in shaping the future of the autotransfusion blood bags market, creating opportunities for collaboration, innovation, and growth.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Vygon SA
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 HemoCue AB
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Macopharma
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Grifols S.A.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 JMS Co., Ltd.
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Medtronic plc
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Fresenius Kabi AG
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Terumo Corporation
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 BloodBank Technology
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 HemaCare Corporation
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Cardinal Health, Inc.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Haemonetics Corporation
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Reliance Medical Limited
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Baxter International Inc.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Graham-Field Health Products, Inc.
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Autotransfusion Blood Bags Market, By Application
    • 6.1.1 Orthopedic Surgeries
    • 6.1.2 Cardiovascular Surgeries
    • 6.1.3 Organ Transplantation
    • 6.1.4 Trauma Cases
    • 6.1.5 Others
  • 6.2 Autotransfusion Blood Bags Market, By Product Type
    • 6.2.1 Single Blood Bags
    • 6.2.2 Double Blood Bags
    • 6.2.3 Triple Blood Bags
    • 6.2.4 Quadruple Blood Bags
    • 6.2.5 Quintuple Blood Bags
  • 6.3 Autotransfusion Blood Bags Market, By Distribution Channel
    • 6.3.1 Hospitals
    • 6.3.2 Ambulatory Surgical Centers
    • 6.3.3 Blood Banks
    • 6.3.4 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Autotransfusion Blood Bags Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Autotransfusion Blood Bags market is categorized based on

By Product Type

• Single Blood Bags
• Double Blood Bags
• Triple Blood Bags
• Quadruple Blood Bags
• Quintuple Blood Bags

By Application

• Orthopedic Surgeries
• Cardiovascular Surgeries
• Organ Transplantation
• Trauma Cases
• Others

By Distribution Channel

• Hospitals
• Ambulatory Surgical Centers
• Blood Banks
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Terumo Corporation
• Haemonetics Corporation
• Medtronic plc
• Baxter International Inc.
• Grifols S.A.
• Fresenius Kabi AG
• BloodBank Technology
• Macopharma
• JMS Co., Ltd.
• Reliance Medical Limited
• Cardinal Health, Inc.
• Vygon SA
• HemoCue AB
• HemaCare Corporation
• Graham-Field Health Products, Inc.